Suven Life Sciences, a Hyderabad based pharma company, has received US FDA acceptance for its Suryapet facility for manufacture and supply intermediates for active pharmaceutical ingredients (API). The company recently undergone US FDA inspection at Suryapet, Nalgonda District in Andhra Pradesh.

This is the second facility in Suven to have US FDA acceptance. Earlier it received acceptance for its Pashmylaram facility during 2007.

So far, the company has filed 11 DMFs out of which 3 are on behalf of customers. With pending ANDA approvals Suven can supply the API in addition to regulated intermediates for bulk APIs in the near future thus generating new revenues in due course of time.